[ {
  "sentence_tokens" : [ "It", "binds", "with", "high", "affinity", "to", "the", "VEGF-A", "isoforms", ",", "thus", "preventing", "binding", "of", "VEGF-A", "to", "its", "receptors", "(", "European", "Medicines", "Agency", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
  "type" : "Negative_regulation",
  "polarity" : false,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 12, 13, 14, 15, 16, 17 ],
  "trigger_indices" : [ 11, 12 ],
  "rule_name" : "Negative_regulation_syntax_1_verb, pronominalMatch",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "resultant", "hypoxia", "then", "further", "up-regulate", "VEGF", "levels", "again", "(", "Storkebaum", "and", "Carmeliet", ",", "2004", ")", "." ],
  "event_indices" : [ 2, 3, 4, 5, 6, 7, 8 ],
  "type" : "Positive_regulation",
  "polarity" : true,
  "controller_indices" : [ 2, 3 ],
  "controlled_indices" : [ 6, 7, 8 ],
  "trigger_indices" : [ 5, 6 ],
  "rule_name" : "Positive_regulation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "VEGF", "administration", "inhibits", "DA", "neurons", "loss", "in", "PD", "models", ",", "especially", "in", "the", "substantia", "nigra", "and", "in", "the", "striatum", "(", "Sheikh", "et", "al", ".,", "2017", ")", ",", "thus", "representing", "a", "potential", "therapeutic", "target", "for", "prevention", "of", "DA", "neuron", "death", "and", "PD", "progression", "." ],
  "event_indices" : [ 0, 1, 2, 3, 4 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 0, 1 ],
  "controlled_indices" : [ 3, 4 ],
  "trigger_indices" : [ 2, 3 ],
  "rule_name" : "Negative_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "The", "state", "of", "brain", "hypoxia", "up-regulates", "VEGF", "and", "its", "subsequent", "higher", "levels", "mediate", "angiogenesis", ",", "causing", "microvascular", "leakage", "and", "fragility", "." ],
  "event_indices" : [ 8, 9, 10, 11, 12, 13, 14 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 8, 9, 10, 11, 12 ],
  "controlled_indices" : [ 13, 14 ],
  "trigger_indices" : [ 12, 13 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "It", "has", "been", "postulated", "that", "reduced", "VEGF", "levels", "may", "cause", "neurodegeneration", ",", "by", "impairing", "neural", "tissue", "perfusion", ",", "thus", "causing", "ischemia", "and", "production", "of", "free", "radicals", "(", "Storkebaum", "and", "Carmeliet", ",", "2004", ")", "." ],
  "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 6, 7, 8 ],
  "controlled_indices" : [ 20, 21 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "However", ",", "the", "use", "of", "anti-VEGF", "drugs", ",", "which", "are", "on", "the", "market", "since", "2005", ",", "was", "not", "considered", "in", "any", "of", "the", "studies", "and", "it", "cannot", "be", "excluded", "that", "anti-VEGF", "drugs", "rather", "than", "AMD", "itself", "triggered", "the", "clinical", "manifestation", "of", "PD", "." ],
  "event_indices" : [ 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 30, 31 ],
  "controlled_indices" : [ 41, 42 ],
  "trigger_indices" : [ 36, 37 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "However", ",", "the", "use", "of", "anti-VEGF", "drugs", ",", "which", "are", "on", "the", "market", "since", "2005", ",", "was", "not", "considered", "in", "any", "of", "the", "studies", "and", "it", "cannot", "be", "excluded", "that", "anti-VEGF", "drugs", "rather", "than", "AMD", "itself", "triggered", "the", "clinical", "manifestation", "of", "PD", "." ],
  "event_indices" : [ 34, 35, 36, 37, 38, 39, 40, 41, 42 ],
  "type" : "Positive_activation",
  "polarity" : true,
  "controller_indices" : [ 34, 35 ],
  "controlled_indices" : [ 41, 42 ],
  "trigger_indices" : [ 36, 37 ],
  "rule_name" : "Positive_activation_syntax_1_verb",
  "rule" : null
}, {
  "sentence_tokens" : [ "Mechanisms", "of", "neurodegeneration", "hypothesized", "in", "PD", "include", "abnormal", "alpha-synuclein", "degradation", "by", "the", "ubiquitin", "-", "proteasome", "system", "and", "the", "lysosomal", "autophagy", "system", ",", "propagation", "of", "alpha-synuclein", "with", "a", "prion", "like", "mechanism", ",", "mitochondrial", "dysfunction", ",", "oxidative", "stress", ",", "and", "neuroinflammation", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ],
  "event_indices" : [ 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 12, 13 ],
  "controlled_indices" : [ 19, 20 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Negative_activation_syntax_2_noun",
  "rule" : null
}, {
  "sentence_tokens" : [ "Mechanisms", "of", "neurodegeneration", "hypothesized", "in", "PD", "include", "abnormal", "alpha-synuclein", "degradation", "by", "the", "ubiquitin", "-", "proteasome", "system", "and", "the", "lysosomal", "autophagy", "system", ",", "propagation", "of", "alpha-synuclein", "with", "a", "prion", "like", "mechanism", ",", "mitochondrial", "dysfunction", ",", "oxidative", "stress", ",", "and", "neuroinflammation", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ],
  "event_indices" : [ 8, 9, 10, 11, 12, 13 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 12, 13 ],
  "controlled_indices" : [ 8, 9 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Negative_activation_syntax_2_noun",
  "rule" : null
}, {
  "sentence_tokens" : [ "Mechanisms", "of", "neurodegeneration", "hypothesized", "in", "PD", "include", "abnormal", "alpha-synuclein", "degradation", "by", "the", "ubiquitin", "-", "proteasome", "system", "and", "the", "lysosomal", "autophagy", "system", ",", "propagation", "of", "alpha-synuclein", "with", "a", "prion", "like", "mechanism", ",", "mitochondrial", "dysfunction", ",", "oxidative", "stress", ",", "and", "neuroinflammation", "(", "Poewe", "et", "al", ".,", "2017", ")", "." ],
  "event_indices" : [ 9, 10, 11, 12, 13, 14, 15 ],
  "type" : "Negative_activation",
  "polarity" : false,
  "controller_indices" : [ 12, 13 ],
  "controlled_indices" : [ 14, 15 ],
  "trigger_indices" : [ 9, 10 ],
  "rule_name" : "Negative_activation_syntax_2_noun",
  "rule" : null
}, {
  "sentence_tokens" : [ "Long-Term", "Intravitreal", "Ranibizumab", "as", "a", "Potential", "Additional", "Risk", "Factor", "for", "Neurodegeneration", "in", "Parkinson", "'s", "Disease", ":", "A", "Case", "Report", "." ],
  "entity_one_indices" : [ 12, 13, 14, 15 ],
  "entity_two_indices" : [ 7, 8, 9 ]
}, {
  "sentence_tokens" : [ "A", "diagnosis", "of", "clinically", "established", "PD", "was", "made", "based", "on", "new", "criteria", "of", "the", "Movement", "Disorders", "Society", "." ],
  "entity_one_indices" : [ 14, 15, 16 ],
  "entity_two_indices" : [ 5, 6 ]
}, {
  "sentence_tokens" : [ "In", "November", "2012", ",", "a", "72-year", "old", "man", "was", "diagnosed", "with", "wet", "AMD", "in", "his", "left", "eye", ",", "based", "on", "fundus", "examination", "and", "optical", "coherence", "tomography", "(", "OCT", ")", ",", "which", "was", "requested", "for", "the", "onset", "of", "metamorphopsia", "." ],
  "entity_one_indices" : [ 27, 28 ],
  "entity_two_indices" : [ 12, 13 ]
}, {
  "sentence_tokens" : [ "Dilated", "fundus", "examination", "revealed", "a", "subretinal", "whitish", "mass", "and", "adjacent", "subretinal", "hemorrhage", "." ],
  "entity_one_indices" : [ 11, 12 ],
  "entity_two_indices" : [ 7, 8 ]
}, {
  "sentence_tokens" : [ "OCT", "confirmed", "the", "presence", "of", "a", "subretinal", "lesion", "and", "intraretinal", "edema", "." ],
  "entity_one_indices" : [ 10, 11 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "After", "obtaining", "informed", "consent", ",", "the", "patient", "was", "monthly", "treated", "with", "intravitreal", "administration", "of", "0.5", "mg", "ranibizumab", "for", "three", "months", ",", "without", "any", "complication", "and", "with", "complete", "retinal", "hemorrhage", "and", "edema", "resolution", "and", "increased", "visual", "acuity", "of", "left", "eye", "(", "10/10", ")", "." ],
  "entity_one_indices" : [ 30, 31 ],
  "entity_two_indices" : [ 27, 28, 29 ]
}, {
  "sentence_tokens" : [ "In", "May", "2015", ",", "visual", "acuity", "further", "reduced", "to", "3/10", "and", "both", "fundus", "examination", "and", "OCT", "revealed", "a", "reactivation", "of", "the", "neovascular", "membrane", ",", "edema", "and", "pigment", "epithelial", "detachment", "." ],
  "entity_one_indices" : [ 24, 25 ],
  "entity_two_indices" : [ 15, 16 ]
}, {
  "sentence_tokens" : [ "In", "the", "same", "period", ",", "the", "patient", "referred", "to", "the", "Movement", "Disorders", "Clinic", "due", "to", "intermittent", "tremor", "on", "the", "left", "hand", ",", "started", "around", "February", "2016", "." ],
  "entity_one_indices" : [ 16, 17 ],
  "entity_two_indices" : [ 10, 11, 12 ]
}, {
  "sentence_tokens" : [ "The", "patient", "had", "no", "family", "history", "of", "PD", "or", "other", "neurodegenerative", "diseases", "nor", "had", "he", "been", "ever", "exposed", "to", "pesticides", "." ],
  "entity_one_indices" : [ 10, 11, 12 ],
  "entity_two_indices" : [ 7, 8 ]
}, {
  "sentence_tokens" : [ "A", "diagnosis", "of", "clinically", "established", "PD", "was", "made", "based", "on", "new", "criteria", "of", "the", "Movement", "Disorders", "Society", "(", "Postuma", "et", "al", ".,", "2015", ")", "." ],
  "entity_one_indices" : [ 14, 15, 16 ],
  "entity_two_indices" : [ 5, 6 ]
}, {
  "sentence_tokens" : [ "Ranibizumab", "is", "a", "humanized", "recombinant", "monoclonal", "antibody", "fragment", "targeted", "against", "human", "VEGF", "." ],
  "entity_one_indices" : [ 11, 12 ],
  "entity_two_indices" : [ 0, 1 ]
}, {
  "sentence_tokens" : [ "Accessed", "01", "Feb", "2018", ")", ",", "following", "monthly", "intravitreal", "injections", "in", "AMD", "patients", ",", "serum", "concentrations", "of", "ranibizumab", "generally", "range", "between", "0.79", "and", "2.90", "ng/ml", "." ],
  "entity_one_indices" : [ 17, 18 ],
  "entity_two_indices" : [ 11, 12 ]
}, {
  "sentence_tokens" : [ "Such", "concentrations", "are", "below", "the", "drug", "concentration", "necessary", "to", "inhibit", "the", "VEGF", "activity", "by", "50", "%", "(", "IC", "=", "11", "-", "27", "ng/ml", ")", "." ],
  "entity_one_indices" : [ 17, 18, 19, 20, 21, 22, 23 ],
  "entity_two_indices" : [ 11, 12 ]
}, {
  "sentence_tokens" : [ "Results", "from", "clinical", "trials", "documented", "no", "significant", "reduction", "in", "serum", "VEGF", "levels", "within", "the", "first", "1", "month", "of", "treatment", "(", "Zehetner", "et", "al", ".,", "2015", ")", ",", "but", "a", "significant", "decline", "in", "systemic", "VEGF", "levels", "was", "detected", "after", "1", "and", "2", "years", "(", "Enders", "et", "al", ".,", "2015", ")", "." ],
  "entity_one_indices" : [ 33, 34 ],
  "entity_two_indices" : [ 10, 11 ]
}, {
  "sentence_tokens" : [ "Furthermore", ",", "a", "meta-analysis", "of", "randomized", "trials", "on", "ranibizumab", "for", "AMD", "treatment", "identified", "a", "stronger", "relationship", "of", "systemic", "vascular", "adverse", "events", "and", "intravitreal", "administration", "of", "VEGF", "inhibitors", "in", "case", "of", "more", "intensive", "treatment", "schedule", "(", "Ueta", "et", "al", ".,", "2014", ")", "." ],
  "entity_one_indices" : [ 25, 26, 27 ],
  "entity_two_indices" : [ 10, 11 ]
}, {
  "sentence_tokens" : [ "Recent", "evidence", "suggested", "that", "the", "VEGF", "signal", "pathway", "may", "directly", "and", "indirectly", "improve", "DA", "neuron", "survival", "(", "Silverman", "et", "al", ".,", "1999", ";", "Pitzer", "et", "al", ".,", "2003", ";", "Yasuhara", "et", "al", ".,", "2004", ")", "." ],
  "entity_one_indices" : [ 13, 14 ],
  "entity_two_indices" : [ 5, 6 ]
}, {
  "sentence_tokens" : [ "This", "hypothesis", "is", "consistent", "with", "a", "recent", "autopsy", "study", "in", "patients", "with", "dementia", "with", "Lewy", "body", ",", "in", "whom", "VEGF", "deficiency", "has", "been", "associated", "with", "a", "loss", "of", "microvessels", "and", "low", "occipital", "blood", "flow", "(", "Miners", "et", "al", ".,", "2014", ")", "." ],
  "entity_one_indices" : [ 19, 20 ],
  "entity_two_indices" : [ 12, 13 ]
}, {
  "sentence_tokens" : [ "These", "changes", "lead", "to", "edema", ",", "bleeding", ",", "and", "impair", "neural", "tissue", "perfusion", "." ],
  "entity_one_indices" : [ 6, 7 ],
  "entity_two_indices" : [ 4, 5 ]
}, {
  "sentence_tokens" : [ "A", "recent", "study", "on", "the", "Italian", "ADR", "Spontaneous", "Reporting", "System", "showed", "3", "reports", "of", "\"", "extrapyramidal", "syndrome", "\"", "due", "to", "intravitreal", "bevacizumab", "and", "1", "to", "intravitreal", "aflibercept", "(", "Cutroneo", "et", "al", ".,", "2017", ")", "." ],
  "entity_one_indices" : [ 16, 17 ],
  "entity_two_indices" : [ 6, 7 ]
}, {
  "sentence_tokens" : [ "On", "the", "other", "hand", ",", "the", "onset", "of", "such", "disorders", "may", "be", "due", "to", "vascular", "events", "and/or", "stroke", ",", "which", "are", "well", "known", "and", "listed", "risks", "of", "intravitreal", "therapy", "with", "anti-VEGF", "drugs", "in", "general", ",", "including", "ranibizumab", "." ],
  "entity_one_indices" : [ 36, 37 ],
  "entity_two_indices" : [ 17, 18 ]
}, {
  "sentence_tokens" : [ "Finally", ",", "a", "meta-analysis", "of", "randomized", "trials", "on", "ranibizumab", "for", "AMD", "treatment", "identified", "a", "stronger", "relationship", "of", "systemic", "vascular", "adverse", "events", "and", "intravitreal", "administration", "of", "VEGF", "inhibitors", "in", "case", "of", "more", "intensive", "treatment", "schedule", "(", "Ueta", "et", "al", ".,", "2014", ")", "." ],
  "entity_one_indices" : [ 25, 26, 27 ],
  "entity_two_indices" : [ 10, 11 ]
}, {
  "sentence_tokens" : [ "All", "the", "above", "described", "experimental", "and", "epidemiological", "evidence", "raise", "the", "hypothesis", "that", "persistent", "and", "intensive", "VEGF", "inhibition", "concurred", "to", "DA", "degeneration", "in", "our", "patient", "." ],
  "entity_one_indices" : [ 19, 20 ],
  "entity_two_indices" : [ 15, 16 ]
}, {
  "sentence_tokens" : [ "Chung", "et", "al.", "(", "2014", ")", "investigated", "the", "risk", "of", "developing", "PD", "within", "3", "years", "after", "the", "AMD", "diagnosis", "in", "a", "retrospective", "cohort", ",", "population", "based", ",", "claims", "database", "study", "in", "Taiwan", "." ],
  "entity_one_indices" : [ 17, 18 ],
  "entity_two_indices" : [ 11, 12 ]
}, {
  "sentence_tokens" : [ "On", "the", "contrary", ",", "a", "case-control", "study", "found", "no", "statistically", "significant", "differences", "in", "the", "frequency", "of", "AMD", "between", "patients", "with", "idiopathic", "PD", "and", "healthy", "subjects", "(", "Nowacka", "et", "al", ".,", "2014", ")", "." ],
  "entity_one_indices" : [ 21, 22 ],
  "entity_two_indices" : [ 16, 17 ]
}, {
  "sentence_tokens" : [ "Using", "claims", "databases", "from", "the", "United", "States", ",", "Brilliant", "et", "al.", "(", "2016", ")", "found", "that", "around", "70", "%", "of", "the", "levodopa", "users", "started", "the", "drug", "treatment", "after", "AMD", "diagnosis", "." ],
  "entity_one_indices" : [ 28, 29 ],
  "entity_two_indices" : [ 21, 22 ]
}, {
  "sentence_tokens" : [ "EM", ",", "CT", ",", "and", "FM", "collected", "the", "data", "and", "performed", "the", "investigation", "." ],
  "entity_one_indices" : [ 5, 6 ],
  "entity_two_indices" : [ 2, 3 ]
}, {
  "sentence_tokens" : [ "ES", "and", "FM", "critically", "reviewed", "the", "manuscript", "for", "important", "intellectual", "content", "and", "suggested", "valuable", "comments", ",", "which", "improved", "the", "quality", "of", "the", "manuscript", "." ],
  "entity_one_indices" : [ 2, 3 ],
  "entity_two_indices" : [ 0, 1 ]
} ]